Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-29 4:05 pm Sale |
2025-06-30 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 149,895 4.400% |
-56,501 (-27.37%) |
Filing History |
| 2025-05-08 5:53 pm Sale |
2025-05-02 | 13D | IN8bio, Inc. INAB |
BIOS Fund II LP | 304,002 9.990% |
-43,203 (-12.44%) |
Filing History |
| 2025-02-14 4:41 pm Purchase |
2024-12-31 | 13G | IN8bio, Inc. INAB |
Ho William Tai-Wei | 136,627 5.600% |
32,410 (+31.10%) |
Filing History |
| 2025-02-14 4:29 pm Purchase |
2024-12-31 | 13G | IN8bio, Inc. INAB |
Alyeska Investment Group L.P. | 241,369 9.900% |
241,369 (New Position) |
Filing History |
| 2025-01-31 4:05 pm Sale |
2024-12-31 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 206,396 8.500% |
-18,202 (-8.10%) |
Filing History |
| 2024-10-11 6:01 pm Unchanged |
2024-10-04 | 13D | IN8bio, Inc. INAB |
BIOS Fund II LP | 347,206 23.100% |
0 (Unchanged) |
Filing History |
| 2024-10-09 5:19 pm Purchase |
2024-10-01 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 224,598 9.300% |
146,775 (+188.60%) |
Filing History |
| 2024-09-17 7:30 pm Sale |
2024-06-14 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 77,822 4.990% |
-58,790 (-43.03%) |
Filing History |
| 2024-02-13 4:04 pm Purchase |
2023-12-31 | 13G | IN8bio, Inc. INAB |
Ho William Tai-Wei | 104,217 7.100% |
7,520 (+7.78%) |
Filing History |
| 2023-12-15 4:31 pm Sale |
2023-12-13 | 13G | IN8bio, Inc. INAB |
Transcend Partners Opportunity Fund I LLC | 107,416 7.500% |
-29,649 (-21.63%) |
Filing History |
| 2023-12-15 06:26 am Purchase |
2023-12-11 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 136,612 9.400% |
136,612 (New Position) |
Filing History |
| 2023-12-15 06:08 am Purchase |
2023-12-13 | 13D | IN8bio, Inc. INAB |
BIOS Fund II LP | 347,206 23.100% |
125,943 (+56.92%) |
Filing History |
| 2023-08-11 4:28 pm Purchase |
2021-12-31 | 13G | IN8bio, Inc. INAB |
Ho William Tai-Wei | 96,697 9.100% |
96,697 (New Position) |
Filing History |
| 2023-08-11 4:18 pm Purchase |
2021-08-03 | 13G | IN8bio, Inc. INAB |
Transcend Partners Opportunity Fund I LLC | 137,065 13.000% |
137,065 (New Position) |
Filing History |
| 2021-08-13 4:16 pm Purchase |
2021-08-03 | 13D | IN8bio, Inc. INAB |
BIOS Fund II LP | 221,263 35.400% |
221,263 (New Position) |
Filing History |